32 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
is expected to result in a reduction in workforce of 30% by the end of 2024, including 35 employees associated with the ophthalmology divestiture … of the reduction of workforce in 2024; and Coherus’ expectations that it will be able to realize value in the future from its pipeline.
Such forward-looking
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
of intangible assets, loss on debt extinguishment and restructuring charges related to our reduction in workforce. These non-GAAP financial measures … on debt extinguishment
Restructuring charges related to reduction in workforce(1)
Acquisition-related costs, including amortization of intangibles(2)
Non
8-K/A
EX-99.1
CHRS
Coherus Biosciences Inc
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
to patients. The Company also implemented a corporate restructuring which reduced its workforce by approximately 20%. The majority of the personnel … in the termination of approximately 50% of the Company’s remaining workforce (the “June Reduction in Force”). In connection with the June Reduction in Force
8-K
EX-99.1
aay 7b2xadl01zq7
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
ln21 m9d3q8
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
kz3g5 nzr
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
3cqc8d
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
v4q9ac5i3zq
16 Jun 23
Business combination disclosure
5:12pm
425
aecj njdo3kt90lqq75d
16 Jun 23
Business combination disclosure
8:08am
425
k3fei 6762pc
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
pi5crnx2aqb
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
7as3w
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
p5x7g8b 6nq0vh7
8 May 23
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
4:16pm